ReviewNature reviews. Urology2014
Reducing infection rates after prostate biopsy.
Review in Nature reviews. Urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.
- The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.World journal of urology · 2018Pooled it
- Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study.International urology and nephrology · 2024Trial
- Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018Trial
- Preclinical evaluation of PSMA-targeted ultrasound contrast agents in an orthotopic model of prostate cancer in rabbits.Bioactive materials · 2027Article
- The clinical utility of prostate MRI before biopsy.Nature reviews. Urology · 2026Review
- Deciphering the urinary microbiome and urological cancers: from correlation to mechanisms and treatment.Frontiers in microbiology · 2025Review
- Transrectal prostate biopsy: easy, effective and safe.Prostate cancer and prostatic diseases · 2024Article
- Article
- Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification.BJUI compass · 2022Article
- Evaluating the diagnostic role of in-bore magnetic resonance imaging guided prostate biopsy: a single-centre study.ANZ journal of surgery · 2022Article
- Association of Warmer Weather and Infectious Complications Following Transrectal Ultrasound-Guided Prostate Biopsy.Journal of personalized medicine · 2022Article
- [Antibiotic prophylaxis for transrectal prostate biopsy : In the context of restricted indications for fluoroquinolones and antibiotic stewardship].Der Urologe. Ausg. A · 2022Article
- Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry.World journal of urology · 2020Review
- Fiducial markers implantation for prostate image-guided radiotherapy: a report on the transperineal approach.La Radiologia medica · 2019Article
- New Bacterial Infection in the Prostate after Transrectal Prostate Biopsy.Journal of Korean medical science · 2018Article
- A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy.Scientific reports · 2018Article
- Genes involved in prostate cancer progression determine MRI visibility.Theranostics · 2018Article
- Transrectal Ultrasound-guided Versus Transperineal Mapping Prostate Biopsy: Complication Comparison.Reviews in urology · 2018Article
- TRUS-guided transperineal prostate 12+X core biopsy with template for the diagnosis of prostate cancer.Oncology letters · 2017Article
- Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis.Prostate cancer and prostatic diseases · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the years, prostate biopsy has become the gold-standard technique for diagnosing prostate carcinoma. Worldwide, several million prostate biopsies are performed every year, most commonly using the transrectal approach. Preoperative antibiotic prophylaxis with fluoroquinolones has been shown to be effective for reducing infection rates. However, in recent years, an increase in febrile infection rates after transrectal prostate biopsy (from 1% to 4%) has been reported in retrospective and prospective studies. The predominant risk factor for infection seems to be the presence of fluoroquinolone-resistant bacteria in faeces. Patients at risk of fluoroquinolone resistance should receive carefully selected antibiotics at sufficient concentrations to be effective. Targeted prophylaxis after rectal flora swabbing has been shown to be efficacious compared with empirical antibiotic prophylaxis. Several forms of bowel preparations are under investigation, although none have yet been shown to significantly reduce infection rates. Perineal prostate biopsy is currently being evaluated as a strategy for preventing the inoculation of rectal flora, but limited data support this approach at present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.